REVISYON SDS100

SDS100 · Edinburgh Biosciences Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REVISYON SDS100, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)